Mesalamine recalls

The FDA has published 6 recalls involving Mesalamine since 2017. The latest was reported on 6 Mar 2024. Most were for potency & assay. Teva Pharmaceuticals U has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls6since 2017
Last 12 months0reported
Class I00% of total
Ongoing1latest 6 Mar 2024

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 5 83%Class III 1 17%

Why mesalamine is recalled

Brands

By year

Ongoing mesalamine recalls

1 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIMesalamine Extended-Release Capsules, USP 500mg recalledMesalamineSun Pharmaceutical IndustriesPotency & AssayNationwide

All mesalamine recalls, newest first

6 total

Should you stop taking Mesalamine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.